We're in Boston, MA this week for IO360. Come say hi at Booth 1!

Ozette in the news.

Read all about what we’ve been up to in our latest news and recent publications.

The Insight’s in the Details: Challenges and Opportunities for BioVis Software Tools

BioVis software tools face critical challenges in handling complex analytical workflows and large-scale experimental data, particularly in enabling detailed visual exploration through computational integration, composability, scalability, and bi-directional AI/ML interactions. In this keynote, Fritz Lekschas (Head of Visualization Research) covers how modern software practices and frameworks can address these challenges, illustrated through examples from genomics, single-cell biology, and the broader BioVis community.

Watch Talk

Aggregate Annotated Single-Cell Heatmap Visualizations

The visualization of large-scale single-cell data through heatmaps faces challenges when displaying thousands of samples and phenotypes along with their metadata, primarily due to screen space limitations and perceptual constraints. Devin Lange presents his internship work on a novel visualization technique that leverages data redundancy through intelligent aggregation of similar phenotypes and samples, enabling interactive collapsible heatmaps that can be viewed at multiple levels of detail while maintaining customizability for various use cases.

Watch Talk

Ozette announces new partnership with Bloodworks Northwest.

The partnership will allow Bloodworks Northwest subsidiary, Bloodworks Bio, to leverage Ozette’s Lab and proprietary immune cell population discovery and annotation platform. The partnership will facilitate establishing a ‘gold standard’ in the advancement of cell therapies.

Read More

Ozette’s Cherie Green featured on Bloodworks Northwest podcast.

Listen in as Cherie discusses Ozette’s new partnership with Bloodworks Northwest.

Listen Now

Ozette announces new partnership with Umoja Biopharma.

Leveraging Ozette’s proprietary immune cell population discovery and annotation platform, Umoja will be working to discover novel oncology insights in preclinical models.

Read More

Ozette announces new suite of machine learning-powered computational analysis solutions.

SEATTLE–(BUSINESS WIRE)–Ozette Technologies, Inc., a technology-driven life sciences company, announces the launch of their Assay-to-Insights product, a streamlined, state-of-the-art process to explore the immune system in fresh and frozen samples. Ozette Assay-to-Insights combines three technologies developed by the company: world-class data generation at the Ozette Laboratory under Good Clinical Laboratory Practices (GCLP) guidelines; rapid computational monitoring of pre-defined biomarker endpoints using Ozette Endpoints™; and unbiased discovery and annotation of single-cell cytometry data through Ozette Discovery™. Insights generated from Ozette Endpoints™ and Ozette Discovery™ are made available through the Ozette Platform™, a cloud-based system that enables clinical teams to interact and explore cytometry data in a central dashboard.

Read More